AbSci is a global leader in biomanufacturing technologies. The company’s SoluPro™ expression platform achieves ultra-high yields of soluble and active protein products and enables ultra-high efficiency purification processes. AbSci’s unique approach accelerates drug discovery timelines, increases manufacturing efficiencies, and drastically reduces costs for the biopharmaceutical industry. We are a fearless, intellectually energetic team of scientists continually defining the future of drug discovery and manufacturing for the biopharmaceutical industry. We welcome passionate, imaginative and accomplished scientists who are risk takers, keen to experiment, collaborate and create extraordinary drug discovery and manufacturing tools to disrupt and transform how life-changing biologics are made. Mission: To empower scientists and companies developing life-saving biologics with novel technologies that speed time to market, lower costs, and create revolutionary efficiencies in drug discovery and manufacturing for the biopharmaceutical industry.
1 to 50
TypeCompany - Private
RevenueUnknown / Non-Applicable
IndustryBiotech & Pharmaceuticals
CompetitorsUnknown
Founded2011